Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03055624 · ClinicalTrials.gov registry record · NA
Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia
A NA study of Enlarged Prostate With Lower Urinary Tract Symptoms and Prostatic Hyperplasia, Benign, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT03055624: Completed NA study of Enlarged Prostate With Lower Urinary Tract Symptoms and Prostatic Hyperplasia, Benign, sponsored by University of California, San Diego.
NCT03055624 is a NA study of Enlarged Prostate With Lower Urinary Tract Symptoms and Prostatic Hyperplasia, Benign that has completed, run by University of California, San Diego. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03055624, a NA study of Enlarged Prostate With Lower Urinary Tract Symptoms and Prostatic Hyperplasia, Benign, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigator-initiated study to evaluate the safety and efficacy of prostate artery embolization for the treatment lower urinary tract symptoms in patients with benign prostatic hyperplasia
Primary Outcome
The study protocol was terminated before completion as the device was FDA approved and determined to be safe for the treated patient population.
Conditions Studied
Interventions
- DEVICE Embosphere microparticles for prostate artery embolization
Study Locations (1)
California
- University of California San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2019-02-18 |
| Phase | NA |
What the finished NCT03055624 record still lists
NCT03055624 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Enlarged Prostate With Lower Urinary Tract Symptoms appearing as the primary indexed condition, and to 1 intervention - of which Embosphere microparticles for prostate artery embolization is the first listed.
NCT03055624 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03055624 about?
NCT03055624 is a clinical study titled "Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia". Investigator-initiated study to evaluate the safety and efficacy of prostate artery embolization for the treatment lower urinary tract symptoms in patients with benign prostatic hyperplasia
What is the current status of trial NCT03055624?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2017-03-01. Estimated completion is 2019-02-18.
What conditions does trial NCT03055624 study?
This clinical trial studies the following conditions: Enlarged Prostate With Lower Urinary Tract Symptoms, Prostatic Hyperplasia, Benign.
What interventions are being tested in trial NCT03055624?
The interventions under investigation include: Embosphere microparticles for prostate artery embolization (DEVICE).
Who is sponsoring clinical trial NCT03055624?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03055624 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Enlarged Prostate With Lower Urinary Tract Symptoms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03055624's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI